Advertisement

Human Immunodeficiency Virus-Associated Rashes

  • Elizabeth Crow
  • Ilene Claudius
Chapter

Abstract

Dermatologic manifestations are common in HIV. While an erythematous maculopapular rash can occur in the context of acute HIV infection, most HIV-associated rashes appear more commonly and severely in the setting of significant immunodeficiency. Intensely pruritic lesions could represent eosinophilic folliculitis, while crusted scabies is often mildly pruritic. Severe forms of common diseases, such as seborrheic dermatitis and molluscum contagiosum, are common in patients immunocompromised from HIV. Kaposi’s is an important neoplasm to recognize and is typically painless and nonpruritic with a red, brown, or violaceous discoloration. It is both important to recognize and treat these manifestations of HIV, as well as testing for HIV in patients presenting with these dermatologic conditions.

Keywords

Human immunodeficiency virus Antiretroviral therapy AIDS (acquired immune deficiency syndrome) CD4 count Immunocompromise 

References

  1. 1.
    Centers for Disease Control and Prevention. HIV surveillance report, 2015; vol. 27. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2016. Accessed Feb 2017.
  2. 2.
    Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6:e17502.  https://doi.org/10.1371/journal.pone.0017502.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med. 1996;125:257–64.CrossRefPubMedGoogle Scholar
  4. 4.
    Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002;16:1119–29.CrossRefPubMedGoogle Scholar
  5. 5.
    Bollinger RC, Brookmeyer RS, Mehendale SM, Paranjape RS, Shepherd ME, Gadkari DA, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA. 1997;278:2085–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Pilcher CD, Tien HC, Eron JJ, Vernazza PL, Leu S-Y, Stewart PW, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189:1785–92.  https://doi.org/10.1086/386333.CrossRefPubMedGoogle Scholar
  7. 7.
    Lapins J, Gaines H, Lindbäck S, Lidbrink P, Emtestam L. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDs. 1997;11:67–70.  https://doi.org/10.1089/apc.1997.11.67.CrossRefPubMedGoogle Scholar
  8. 8.
    Rabeneck L, Popovic M, Gartner S, McLean DM, McLeod WA, Read E, et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA. 1990;263:2318–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Calabrese LH, Proffitt MR, Levin KH, Yen-Lieberman B, Starkey C. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med. 1987;107:849–51.CrossRefPubMedGoogle Scholar
  10. 10.
    Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. Primary human T-lymphotropic virus type III infection. Ann Intern Med. 1985;103:880–3.CrossRefPubMedGoogle Scholar
  11. 11.
    Hellmuth J, Fletcher JLK, Valcour V, Kroon E, Ananworanich J, Intasan J, et al. Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology. 2016;87:148–54.  https://doi.org/10.1212/WNL.0000000000002837.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Braun DL, Kouyos RD, Balmer B, Grube C, Weber R, Günthard HF. Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection. Clin Infect Dis. 2015;61:1013–21.  https://doi.org/10.1093/cid/civ398.CrossRefPubMedGoogle Scholar
  13. 13.
    Uthayakumar S, Nandwani R, Drinkwater T, Nayagam AT, Darley CR. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol. 1997;137:595–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Simpson-Dent S, Fearfield LA, Staughton RC. HIV associated eosinophilic folliculitis – differential diagnosis and management. Sex Transm Infect. 1999;75:291–3.  https://doi.org/10.1136/sti.75.5.291.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fearfield LA, Rowe A, Francis N, Bunker CB, Staughton RC. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br J Dermatol. 1999;141:3–11.CrossRefPubMedGoogle Scholar
  16. 16.
    Rosenthal D, LeBoit PE, Klumpp L, Berger TG. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol. 1991;127:206–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Soeprono FF, Schinella RA. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. J Am Acad Dermatol. 1986;14:1020–2.CrossRefPubMedGoogle Scholar
  18. 18.
    Rajendran PM, Dolev JC, Heaphy MR, Maurer T. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol. 2005;141:1227–31.  https://doi.org/10.1001/archderm.141.10.1227.CrossRefPubMedGoogle Scholar
  19. 19.
    Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol. 2004;5:189–97.CrossRefPubMedGoogle Scholar
  20. 20.
    Buchness MR, Lim HW, Hatcher VA, Sanchez M, Soter NA. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy. N Engl J Med. 1988;318:1183–6.  https://doi.org/10.1056/NEJM198805053181807.CrossRefPubMedGoogle Scholar
  21. 21.
    Misago N, Narisawa Y, Matsubara S, Hayashi S. HIV-associated eosinophilic pustular folliculitis: successful treatment of a Japanese patient with UVB phototherapy. J Dermatol. 1998;25:178–84.  https://doi.org/10.1111/j.1346-8138.1998.tb02376.x.CrossRefPubMedGoogle Scholar
  22. 22.
    Porneuf M, Guillot B, Barneon G, Guilhou JJ. Eosinophilic pustular folliculitis responding to UVB therapy. J Am Acad Dermatol. 1993;29 (259–60.CrossRefGoogle Scholar
  23. 23.
    Rau RC, Baird IM. Crusted scabies in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1986;15:1058–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Glover A, Young L, Goltz AW. Norwegian scabies in acquired immunodeficiency syndrome: report of a case resulting in death from associated sepsis. J Am Acad Dermatol. 1987;16 (396–9.CrossRefGoogle Scholar
  25. 25.
    Drabick JJ, Lupton GP, Tompkins K. Crusted scabies in human immunodeficiency virus infection. J Am Acad Dermatol. 1987;17:142.CrossRefPubMedGoogle Scholar
  26. 26.
    Arlian LG, Morgan MS, Estes SA, Walton SF, Kemp DJ, Currie BJ. Circulating IgE in patients with ordinary and crusted scabies. 2004;  https://doi.org/10.1603/0022-2585-41.1.74.
  27. 27.
    Karthikeyan K. Crusted scabies. Indian J Dermatol Venereol Leprol. 2009;75:340–7.  https://doi.org/10.4103/0378-6323.53128.CrossRefPubMedGoogle Scholar
  28. 28.
    Josephine M, Issac E, George A, Ngole M, Albert S-E. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45:280–4.  https://doi.org/10.1111/j.1365-4632.2004.02529.x.CrossRefPubMedGoogle Scholar
  29. 29.
    Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50:375–81.  https://doi.org/10.1016/j.jinf.2004.08.033.CrossRefPubMedGoogle Scholar
  30. 30.
    Lin S, Farber J, Lado L. A case report of crusted scabies with methicillin-resistant Staphylococcus Aureus bacteremia. J Am Geriatr Soc. 2009;57:1713–4.  https://doi.org/10.1111/j.1532-5415.2009.02412.x.CrossRefPubMedGoogle Scholar
  31. 31.
    Friedman-Kien AE. Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Am Acad Dermatol. 1981;5:468–71.  https://doi.org/10.1016/S0190-9622(81)80010-2.CrossRefPubMedGoogle Scholar
  32. 32.
    Goldstein B, Berman B, Sukenik E, Frankel SJ. Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol. 1997;36:262–4.CrossRefPubMedGoogle Scholar
  33. 33.
    S.A. Cancer, Cancer Facts & Figures 2012, 2012.Google Scholar
  34. 34.
    Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol. 1989;125:357–61.CrossRefPubMedGoogle Scholar
  35. 35.
    Goodman DS, Teplitz ED, Wishner A, Klein RS, Burk PG, Hershenbaum E. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987;17:210–20.CrossRefPubMedGoogle Scholar
  36. 36.
    Hira SK, Wadhawan D, Kamanga J, Kavindele D, Macuacua R, Patil PS, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol. 1988;19:451–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Matis WL, Triana A, Shapiro R, Eldred L, Polk BF, Hood AF. Dermatologic findings associated with human immunodeficiency virus infection. J Am Acad Dermatol. 1987;17:746–51.CrossRefPubMedGoogle Scholar
  38. 38.
    Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection.A review of twenty-seven patients. J Am Acad Dermatol. 1992;27:583–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Schwartz JJ, Myskowski PL. Hiv-related MoUuscum contagiosum presenting as a cutaneous horn. Int J Dermatol. 1992;31:142–4.  https://doi.org/10.1111/j.1365-4362.1992.tb03258.x.CrossRefPubMedGoogle Scholar
  40. 40.
    Hicks CB, Myers SA, Giner J. Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis. 1997;24:1023–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Berger RS, Stoner MF, Hobbs ER, Hayes TJ, Boswell RN. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol. 1988;19 (298–303.CrossRefGoogle Scholar
  42. 42.
    Soeprono FF, Schinella RA, Cockerell CJ, Comite SL. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. J Am Acad Dermatol. 1986;14:242–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Muñoz-Pérez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139:33–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Mallal SA. The Western Australian HIV cohort study, Perth, Australia. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(Suppl 1):S23–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1985;13:947–51.CrossRefPubMedGoogle Scholar
  46. 46.
    Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014;28:16–26.  https://doi.org/10.1111/jdv.12197.CrossRefPubMedGoogle Scholar
  47. 47.
    Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med. 2004;5:50–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Elizabeth Crow
    • 1
  • Ilene Claudius
    • 2
  1. 1.Los Angeles County Medical Center, Department of Emergency MedicineLos AngelesUSA
  2. 2.Harbor-UCLA Medical CenterLos AngelesUSA

Personalised recommendations